{
  "meta": {
    "title": "5_Pituitary_Tumours_And_Sheehan_S_Syndrome",
    "url": "https://brainandscalpel.vercel.app/5-pituitary-tumours-and-sheehan-s-syndrome-ea0eb0d0.html",
    "scrapedAt": "2025-11-30T12:28:48.643Z"
  },
  "questions": [
    {
      "text": "What is the most common functioning tumor of the pituitary?",
      "choices": [
        {
          "id": 1,
          "text": "GH-secreting adenoma"
        },
        {
          "id": 2,
          "text": "ACTH-secreting adenoma"
        },
        {
          "id": 3,
          "text": "Gonadotrope adenoma"
        },
        {
          "id": 4,
          "text": "PRL-secreting adenoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Prolactin-secreting adenoma or <strong>prolactinoma</strong> is the most common type of&nbsp;<strong>functioning </strong>pituitary adenoma.&nbsp;<strong>Pituitary adenomas</strong> are the most common type of pituitary tumor, accounting for one-third of all tumors.</p><hr><h3>Related Pearl: Classification of Pituitary Adenomas with Associated Syndromes</h3><p>The various types of pituitary tumors are listed in decreasing order of frequency:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adenoma cell origin</strong></p>\n</td>\n<td>\n<p><strong>Hormone</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactotroph</p>\n</td>\n<td>\n<p>Prolactin</p>\n</td>\n<td>\n<p>Galactorrhea and amenorrhea (in females)</p>\n<p>Sexual dysfunction, infertility</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gonadotroph</p>\n</td>\n<td>FSH, LH subunits</td>\n<td>\n<p>Hypogonadism, mass effects, and hypopituitarism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Somatotroph&nbsp;</p>\n</td>\n<td>\n<p>GH</p>\n</td>\n<td>\n<p>Gigantism (children)</p>\n<p>Acromegaly (adults)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Corticotroph</p>\n</td>\n<td>ACTH</td>\n<td>\n<p>Cushing's disease</p>\n<p>Nelson's syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mammosomatotroph</p>\n</td>\n<td>\n<p>Prolactin, GH</p>\n</td>\n<td>\n<p>Hypogonadism, galactorrhea, acromegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thyrotroph&nbsp;</p>\n</td>\n<td>\n<p>TSH</p>\n</td>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>GH: Growth hormone</p>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone</p>\n<p>TSH:&nbsp;Thyroid-stimulating hormone</p>\n<p>FSH:&nbsp;Follicle-stimulating hormone</p>\n<p>LH:&nbsp;Luteinizing hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6720",
      "difficulty": "medium"
    },
    {
      "text": "What are the most common cells involved in non-functioning pituitary adenoma?",
      "choices": [
        {
          "id": 1,
          "text": "Prolactin-producing cells"
        },
        {
          "id": 2,
          "text": "ACTH-producing cells"
        },
        {
          "id": 3,
          "text": "Gonadotropin-producing cells"
        },
        {
          "id": 4,
          "text": "TSH-producing cells"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Non-functioning</strong> pituitary adenomas most commonly arise from <strong>gonadotropic</strong> cells (80%).&nbsp;</p>\n<p>Pituitary adenomas are classified as functioning or non-functioning based on the secretion of hormones. Non-functioning adenomas are usually <strong>asymptomatic</strong> in the initial stages but as the tumor grows larger, <strong>mass effect</strong> produces clinical manifestations such as:</p>\n<ul>\n<li>Headache</li>\n<li>Bitemporal hemianopia&nbsp;</li>\n<li>Diplopia, ptosis&nbsp;</li>\n<li>Compression of pituitary stalk\n<ul>\n<li>Hyperprolactinemia initially - reduced dopamine release leads to loss of inhibition of lactotrophs</li>\n<li>Hypopituitarism in later stages</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Cells of Anterior Pituitary</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/843ae844c09346af99204e0a0f875354x1280x1382.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6718",
      "difficulty": "hard"
    },
    {
      "text": "A 30-year-old woman with a suspected prolactinoma is planned for a brain MRI. What size would the tumor have to be to call it a microadenoma?",
      "choices": [
        {
          "id": 1,
          "text": "< 10 mm"
        },
        {
          "id": 2,
          "text": "< 20 mm"
        },
        {
          "id": 3,
          "text": "< 5 mm"
        },
        {
          "id": 4,
          "text": "< 15 mm"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Pituitary adenomas<strong> &lt; 10 mm</strong> are called <strong>microadenomas.</strong></p>\n<p>Asymptomatic pituitary tumors can be discovered incidentally on imaging. They must also be suspected in patients with features of hormone hypersecretion or mass effect. In such cases,<strong>&nbsp;MRI with&nbsp;contrast</strong> is the best investigation to detect the tumor, as shown below.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6685836e0f24208af00031ee2b78c4cx720x720.PNG\" alt=\"Explanation Image\"><p>Levels of <strong>pituitary hormones</strong> must also be measured to rule out both hypersecretion and&nbsp;hyposecretion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6719",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following would not occur in a patient with a pituitary macroadenoma?",
      "choices": [
        {
          "id": 1,
          "text": "Increased insulin sensitivity"
        },
        {
          "id": 2,
          "text": "Pigmentation of mucous membranes"
        },
        {
          "id": 3,
          "text": "Low serum thyroxine and TSH levels"
        },
        {
          "id": 4,
          "text": "Loss of secondary sexual characteristics"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Pituitary <strong>macroadenomas</strong>&nbsp;do not cause pigmentation of mucous membranes as ACTH levels are low.</p>\n<p>In this condition, there is destruction of the pituitary gland by mass effect. This leads to <strong>panhypopituitarism</strong> or reduced levels of all hormones, including ACTH. Excessive pigmentation is only seen in cases of excess ACTH.</p>\n<p>The following hormones are deficient in panhypopituitarism:</p>\n<ul>\n<li>ACTH - Secondary adrenal insufficiency</li>\n<li>TSH -&nbsp;Secondary hypothyroidism</li>\n<li>GH - Growth failure and adult hyposomatotropism</li>\n<li>FSH, LH - Hypogonadic hypogonadism</li>\n<li>Prolactin - Lactation failure</li>\n</ul>\n<p><strong>Adiponectin</strong>, secreted by fat cells normally increases insulin sensitivity. It is usually suppressed by cortisol. In panhypopituitarism, <strong>decreased</strong> <strong>cortisol</strong> levels lead to increased <strong>insulin sensitivity</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6724",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following can occur in a patient with prolactinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Superior quadrantanopia"
        },
        {
          "id": 2,
          "text": "Inferior quadrantanopia"
        },
        {
          "id": 3,
          "text": "Priapism"
        },
        {
          "id": 4,
          "text": "Failure of lactation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Superior quadrantanopia</strong> may be seen in patients with <strong>prolactinoma&nbsp;</strong>&gt; 10 mm in size (macroadenoma).</p>\n<p>In this condition, visual field defects occur due to compression of the optic chiasm. In the initial stages, the pituitary tumor tends to compress the <strong>ventral</strong> portion of the<strong> optic chiasm</strong>. This causes a <strong>bitemporal</strong>&nbsp;(heteronymous) superior field defect. As the tumor grows larger, the entire optic chiasm gets compressed, leading to complete bitemporal hemianopia, as shown below.&nbsp;</p><p>Damage to the <strong>optic radiation</strong> in the temporal lobe would result in <strong>homonymous</strong> <strong>superior</strong> <strong>quadrantanopia</strong> or pie-in-the-sky appearance.</p><hr><h3>Related Pearl: Lesions in the optic pathway</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/99e36d0f854b491da018065066ccac41x1280x2202.PNG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e6706752b2243f395c0320ea0a3ef7cx1280x1910.JPEG\" alt=\"Pearl Image\"><p><strong>Transection</strong> of the <strong>pathways</strong> at the locations indicated by the letters causes the visual field defects shown in the diagram above.</p>\n<ul>\n<li>The fibers from the nasal half of each retina decussate in the optic chiasm, so that the fibers in the optic tracts are those from the temporal half of one retina and the nasal half of the other.</li>\n<li>A <strong>lesion</strong> that interrupts<strong>&nbsp;the</strong>&nbsp;<strong>optic nerve</strong> causes <strong>blindness</strong> in <strong>that eye</strong>.</li>\n<li><strong>Lesions</strong> affecting the <strong>optic chiasma</strong> destroy fibers from both nasal hemiretinas and produce a <strong>heteronymous</strong> (opposite sides of the visual fields) <strong>hemianopia.</strong></li>\n<li>A <strong>lesion</strong> in <strong>one optic tract</strong> causes blindness in half of the visual field and is called <strong>homonymous</strong> (same side of both visual fields)&nbsp;<strong>hemianopia (half-blindness).</strong></li>\n<li><strong>Occipital lesions</strong> may <strong>spare</strong> the fibers from the <strong>macula</strong>&nbsp;because of the separation in the brain of these fibers from the other subserving vision.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6687",
      "difficulty": "medium"
    },
    {
      "text": "What levels of prolactin are definitely suggestive of prolactinoma?",
      "choices": [
        {
          "id": 1,
          "text": ">50μg/L"
        },
        {
          "id": 2,
          "text": ">100μg/L"
        },
        {
          "id": 3,
          "text": ">150μg/L"
        },
        {
          "id": 4,
          "text": ">200μg/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The diagnosis of a <strong>prolactinoma</strong> is highly likely when prolactin levels are <strong>&gt; 200 &mu;g/L</strong>.</p>\n<p>The <strong>normal</strong> range of serum prolactin (PRL) is <strong>5-20 &mu;g/L</strong>. Prolactin levels &lt; 100 &mu;g/L can be due to non-functioning pituitary adenomas or non-neoplastic causes of hyperprolactinemia. MRI brain must be done in all patients with hyperprolactinemia.</p>\n<p>Prolactinoma are tumors arising from the <strong>lactotroph cells</strong> of the <strong>pituitary gland</strong>, they can be classified as <strong>microadenoma</strong>(&lt;1cm in diameter, usually non invasive ) or <strong>macroadenoma</strong>(&gt;1cm, locally invasive to adjacent structures). Clinical features include amenorrhea, infertility, and galactorrhea in women, impotence, loss of libido, infertility in men and if tumor extends beyond sella, there can be visual field defects and other mass effects. </p>\n<p>Treatment - In <strong>asymptomatic</strong> patients and those where <strong>fertility is not desired</strong>, they do <strong>not require treatment</strong> and can be monitored using <strong>regular PRL</strong> measurements and <strong>MRI</strong>.&nbsp;In <strong>symptomatic microadenoma</strong> cases, <strong>oral dopamine agonists</strong> (cabergoline and bromocriptine) form the main treatment for hyperprolactinemia and reduction of tumor volume.&nbsp;For <strong>macroadenoma</strong>, before starting dopamine agonists <strong>visual field testing</strong> is to be done, and reassess it with <strong>MRI changes every 6-12 month</strong> intervals until maximum reduction is achieved, in <strong>unresponsive</strong> cases consider <strong>surgery</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3181",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions do not need to be screened for pituitary tumors?",
      "choices": [
        {
          "id": 1,
          "text": "MEN1"
        },
        {
          "id": 2,
          "text": "MEN2"
        },
        {
          "id": 3,
          "text": "MEN4"
        },
        {
          "id": 4,
          "text": "Carney Complex"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>MEN2</strong> syndrome is not associated with pituitary tumors.&nbsp;It is associated with&nbsp;<strong>medullary</strong> <strong>thyroid</strong> cancer and <strong>pheochromocytoma</strong>.</p>\n<p>The genetic syndromes associated with <strong>pituitary tumors</strong> include:</p>\n<ul>\n<li>MEN1</li>\n<li>MEN4</li>\n<li>Carney complex tumors</li>\n<li>McCune-Albright Syndrome</li>\n</ul><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6721",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old woman presented with a gradually diminishing visual field. She was found to have a pituitary mass and underwent trans-sphenoidal hypophysectomy. Now she has low levels of ACTH, TSH, FSH, and LH. Which of the following hormone supplements is not needed in the patient postoperatively?",
      "choices": [
        {
          "id": 1,
          "text": "Mineralocorticoids"
        },
        {
          "id": 2,
          "text": "Thyroid hormones"
        },
        {
          "id": 3,
          "text": "Glucocorticoids"
        },
        {
          "id": 4,
          "text": "Estradiol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario describes a woman presenting with <strong>hypopituitarism</strong> <strong>following trans-sphenoidal resection</strong>. <strong>Mineralocorticoid supplementation</strong> is <strong>not</strong> needed <strong>postoperatively</strong> as it is <strong>regulated by</strong> the <strong>renin-angiotensin-aldosterone system</strong> and <strong>not</strong> by <strong>ACTH</strong>. Therefore, mineralocorticoid levels would remain intact despite ACTH deficiency.</p>\n<p><strong>Thyroid hormone</strong>, <strong>estradiol</strong>, and <strong>glucocorticoid supplementation</strong> are needed in this patient as their secretion is regulated by anterior pituitary hormones.</p>\n<p>Features of hypopituitarism include <strong>growth abnormalities in children</strong> with a growth hormone deficiency, insufficient levels of gonadotropins leading to <strong>menstrual irregularities</strong>, <strong>infertility</strong> in women and <strong>reduced sexual function</strong>, infertility and <strong>loss of secondary sexual characteristics </strong>in<strong> men</strong>. TSH deficiency leads to stunted growth in children and features of hypothyroidism in both children and adults. ACTH deficiency leads to secondary adrenal insufficiency.</p>\n<p>Polyuria and polydipsia may be seen and indicate a loss of vasopressin secretion in posterior pituitary lesions.</p>\n<p>The following hormones must be replaced post-hypophysectomy:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Trophic hormone deficit</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hormone Replacement</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ACTH</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hydrocortisone, cortisone acetate, prednisone&nbsp;</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>TSH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>L-thyroxine (75&ndash;150 &micro;g daily)</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>FSH/LH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">Males: Testosterone</div>\n<div class=\"page\" title=\"Page 2713\">&nbsp;</div>\n<div class=\"page\" title=\"Page 2713\">Females:&nbsp;\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>For fertility: menopausal gonadotropins, hCG</p>\n<p>Post-menopausal women:&nbsp;Conjugated estrogen, progesterone</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>GH</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Somatotropin</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Vasopressin</td>\n<td>\n<div class=\"page\" title=\"Page 2713\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Intranasal desmopressin</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0226",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common clinical presentation in patients with craniopharyngiomas?",
      "choices": [
        {
          "id": 1,
          "text": "Growth retardation"
        },
        {
          "id": 2,
          "text": "Bitemporal hemianopia"
        },
        {
          "id": 3,
          "text": "Headache"
        },
        {
          "id": 4,
          "text": "Endocrinal disturbance"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Headache</strong> is the most common presenting symptom of&nbsp;<strong>craniopharyngioma.</strong></p>\n<p>Craniopharyngiomas are <strong>benign, suprasellar</strong> cystic masses. They have a <strong>bimodal</strong> distribution, occurring predominantly in <strong>children</strong> but also between the ages of 55 and 65 years. It can present with the following clinical symptoms:</p>\n<ul>\n<li>Headache</li>\n<li>Hypopituitarism\n<ul>\n<li>Hypogonadotropic hypogonadism</li>\n<li>Central diabetes insipidus</li>\n</ul>\n</li>\n<li>Bitemporal hemianopia</li>\n<li>Raised ICT - vomiting, papilledema, hydrocephalus</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6723",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old boy is referred for evaluation of progressively worsening headaches and visual field defects. An MRI brain is done and shows the following findings. Which of the following statements is incorrect about this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Composed of epithelial cells"
        },
        {
          "id": 2,
          "text": "Surgery is curative in most patients"
        },
        {
          "id": 3,
          "text": "Contains cholesterol crystals"
        },
        {
          "id": 4,
          "text": "Calcifications are seen in adamantinomatous type"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given MRI showing a <strong>suprasellar&nbsp;</strong>mass with <strong>calcifications</strong> is suggestive of a <strong>craniopharyngioma</strong>. <strong>Surgery</strong> is <strong>not&nbsp;curative</strong> in the majority of patients as the tumor is adherent to surrounding structures.</p>\n<p>They are benign&nbsp;<strong>epithelial</strong> cell-containing tumors and are of two types:</p>\n<ul>\n<li class=\"p1\">Adamantinomatous - <strong>calcifications</strong> and keratin nodules are seen</li>\n<li class=\"p1\">Papillary - calcifications are rare</li>\n</ul>\n<p class=\"p1\">Biopsy reveals machinery or <strong>motor-oil</strong>-like&nbsp;fluid within the cyst that contains <strong>cholesterol crystals</strong>.&nbsp;The treatment of choice is transcranial or transsphenoidal <strong>resection.</strong>&nbsp;It must be followed by&nbsp;postoperative <strong>radiation&nbsp;</strong>to prevent&nbsp;<strong>recurrence.</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8c6b875818094331a298a1c5f874a13e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6722",
      "difficulty": "hard"
    },
    {
      "text": "Patients with which of the following conditions are not at risk for pituitary apoplexy?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperthyroidism"
        },
        {
          "id": 2,
          "text": "Diabetes mellitus"
        },
        {
          "id": 3,
          "text": "Sickle cell anemia"
        },
        {
          "id": 4,
          "text": "Hypertension"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pituitary apoplexy</strong> does not occur in hyperthyroidism. It&nbsp;is a rare endocrine emergency which can occur due to&nbsp;<strong>haemorrhage</strong>&nbsp;or<strong>&nbsp;infarction</strong>&nbsp;of the pituitary gland. It may&nbsp;occur as a result of the following conditions:</p>\n<ul>\n<li>Pituitary adenoma (spontaneous)</li>\n<li>Sheehan syndrome</li>\n<li>Acute shock</li>\n<li>Diabetes mellitus</li>\n<li>Hypertension</li>\n<li>Sickle cell anemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6726",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is seen in pituitary apoplexy?",
      "choices": [
        {
          "id": 1,
          "text": "Hypertension"
        },
        {
          "id": 2,
          "text": "Shock"
        },
        {
          "id": 3,
          "text": "Unconsciousness"
        },
        {
          "id": 4,
          "text": "Fatigue"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Shock</strong> is seen in <strong>pituitary apoplexy.</strong></p>\n<p><strong>Loss of consciousness</strong> (Option C) can also be seen but it occurs secondary to <strong>adrenal insufficiency</strong> and <strong>shock</strong>. Hence, shock is the most appropriate answer.</p>\n<p><strong>Pituitary apoplexy</strong> refers to <strong>acute hemorrhagic infarction</strong> of the pituitary gland. This results in the compression of surrounding structures and <strong>hypopituitarism</strong> leading to <strong>acute adrenal insufficiency.</strong> It may be seen spontaneously in a pre-existing pituitary adenoma, post-partum (Sheehan&rsquo;s syndrome), or be associated with hypertension, diabetes mellitus or sickle cell anemia or shock.</p>\n<p>Pituitary apoplexy is an endocrine <strong>emergency</strong> that can lead to severe hypoglycemia, hypotension, shock, central nervous system (CNS) hemorrhage, and death. Acute clinical manifestations commonly encompass intense headaches with signs of meningeal irritation, bilateral visual changes, ophthalmoplegia, and even cardiovascular collapse.</p>\n<p>The investigation of choice is <strong>MRI</strong>.&nbsp;</p>\n<p>Patients who do not exhibit overt visual impairment or altered mental status can be managed conservatively with <strong>high-dose glucocorticoids. </strong>Progressive <strong>visual loss,</strong> <strong>cranial nerve palsy, </strong>or <strong>altered mental status</strong> necessitate expeditious <strong>surgical decompression.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0883",
      "difficulty": "medium"
    },
    {
      "text": "Which hormone is the first to fall in Sheehan syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Prolactin"
        },
        {
          "id": 2,
          "text": "GH"
        },
        {
          "id": 3,
          "text": "FSH"
        },
        {
          "id": 4,
          "text": "ACTH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Growth hormone (<strong>GH</strong>) is the <strong>first</strong> to fall in <strong>Sheehan</strong>&nbsp;syndrome.&nbsp;The hormones are affected in the order of&nbsp;GH&nbsp;&rarr; Prolactin &rarr; LH and FSH &rarr; ACTH &rarr; TSH</p>\n<p>Sheehan syndrome refers to postpartum <strong>pituitary necrosis</strong> following severe postpartum hemorrhage (<strong>PPH</strong>). During pregnancy, the pituitary gland undergoes <strong>hypertrophy</strong> with increased blood supply. This makes it <strong>susceptible</strong> to ischemia and <strong>infarction</strong> when there is severe hypovolemia.</p>\n<p>The clinical presentation depends on the amount of damage to the pituitary.</p>\n<ul>\n<li>Mild - can go unnoticed for many years</li>\n<li>Moderate - develops over months\n<ul>\n<li>Lactation failure</li>\n<li>Failure to resume menses</li>\n<li>Mild fatigue and anorexia</li>\n</ul>\n</li>\n<li>Severe - endocrine emergency that develops within few days\n<ul>\n<li>Hypotension and shock</li>\n<li>Severe hypoglycemia</li>\n<li>Lactation failure</li>\n</ul>\n</li>\n</ul>\n<p>GH deficiency is very common in Sheehan&rsquo;s syndrome because somatotrophs are located in the lower and lateral regions of the pituitary gland, and are most likely to be damaged by ischemic necrosis of the pituitary.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6725",
      "difficulty": "medium"
    },
    {
      "text": "You are a first-year resident in the postpartum ward. During rounds, you see a 28-year-old woman who has been unable to breastfeed since delivery. Her baby was born by normal vaginal delivery that was complicated by severe postpartum hemorrhage. Her blood pressure is 90/50 mm Hg and her pulse is 96/min. What is the next best step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Estrogen"
        },
        {
          "id": 2,
          "text": "Growth hormone"
        },
        {
          "id": 3,
          "text": "Thyroxine"
        },
        {
          "id": 4,
          "text": "Cortisone"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This clinical scenario is suggestive of <strong>Sheehan</strong> syndrome. <strong>Corticosteroids</strong> must be supplemented&nbsp;first, as <strong>life-threatening</strong> manifestations may occur due to the sudden onset of adrenal insufficiency.&nbsp;This is followed by the replacement of other deficient pituitary hormones including thyroid hormone and estrogen administered with or without progesterone.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6727",
      "difficulty": "medium"
    }
  ]
}